Advertisement
Research Article

CB2 Receptor Agonists Protect Human Dopaminergic Neurons against Damage from HIV-1 gp120

  • Shuxian Hu,

    Affiliation: Center for Infectious Diseases and Microbiology Translational Research, Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota Medical School, Minneapolis, Minnesota, United States of America

    X
  • Wen S. Sheng,

    Affiliation: Center for Infectious Diseases and Microbiology Translational Research, Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota Medical School, Minneapolis, Minnesota, United States of America

    X
  • R. Bryan Rock mail

    rockx012@umn.edu

    Affiliation: Center for Infectious Diseases and Microbiology Translational Research, Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota Medical School, Minneapolis, Minnesota, United States of America

    X
  • Published: October 17, 2013
  • DOI: 10.1371/journal.pone.0077577

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.